{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:32:35Z","timestamp":1777339955661,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T00:00:00Z","timestamp":1372204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00380-013-0377-3","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T12:04:24Z","timestamp":1372161864000},"page":"464-469","source":"Crossref","is-referenced-by-count":22,"title":["Novel use of the ultra-short-acting intravenous \u03b21-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure"],"prefix":"10.1007","volume":"29","author":[{"given":"Toru","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Hiraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,26]]},"reference":[{"key":"377_CR1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jama.287.5.628","volume":"287","author":"A Nohria","year":"2002","unstructured":"Nohria A, Lewis E, Stevenson LW (2002) Medical management of advanced heart failure. JAMA 287:628\u2013640","journal-title":"JAMA"},{"key":"377_CR2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946\u2013952","journal-title":"Circulation"},{"key":"377_CR3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","volume":"32","author":"DL Dries","year":"1998","unstructured":"Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32:695\u2013703","journal-title":"J Am Coll Cardiol"},{"key":"377_CR4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-09-0316","volume":"73","author":"S Hamaguchi","year":"2009","unstructured":"Hamaguchi S, Yokoshiki H, Kinugawa S, Tsuchihashi-Makaya M, Yokota T, Takeshita A, Tsutsui H (2009) Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73:2084\u20132090","journal-title":"Circ J"},{"key":"377_CR5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1378\/chest.118.4.914","volume":"118","author":"J Mathew","year":"2000","unstructured":"Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S (2000) Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118:914\u2013922","journal-title":"Chest"},{"key":"377_CR6","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D\u2019Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920\u20132925","journal-title":"Circulation"},{"key":"377_CR7","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","volume":"358","author":"D Roy","year":"2008","unstructured":"Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O\u2019Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667\u20132677","journal-title":"N Engl J Med"},{"key":"377_CR8","author":"S Ishii","year":"2013","unstructured":"Ishii S, Inomata T, Ikeda Y, Nabeta T, Iwamoto M, Watanabe I, Naruke T, Shinagawa H, Koitabashi T, Nishii M, Takeuchi I, Izumi T (2013) Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Heart Vessel. doi: 10.1007\/s00380-013-0335-0","journal-title":"Heart Vessel"},{"key":"377_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.0000021113.44111.3E","volume":"106","author":"E Crystal","year":"2002","unstructured":"Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S (2002) Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106:75\u201380","journal-title":"Circulation"},{"key":"377_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005344-199907000-00012","volume":"34","author":"A Sugiyama","year":"1999","unstructured":"Sugiyama A, Takahara A, Hashimoto K (1999) Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 34:70\u201377","journal-title":"J Cardiovasc Pharmacol"},{"key":"377_CR11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF03016588","volume":"48","author":"J Sasao","year":"2001","unstructured":"Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H (2001) In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 48:985\u2013989","journal-title":"Can J Anaesth"},{"key":"377_CR12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jtcvs.2010.10.045","volume":"141","author":"A Sezai","year":"2011","unstructured":"Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, Shiono M, Hirayama A (2011) Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg 141:1478\u20131487","journal-title":"J Thorac Cardiovasc Surg"},{"key":"377_CR13","author":"H Nishi","year":"2012","unstructured":"Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, Ueno T, Kuratani T, Sawa Y (2012) Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery. Heart Vessel. doi: 10.1007\/s00380-012-0263-4","journal-title":"Heart Vessel"},{"key":"377_CR14","doi-asserted-by":"crossref","unstructured":"Hoshi T, Sato A, Nishina H, Kakefuda Y, Wang Z, Noguchi Y, Aonuma K (2012) Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study. J Cardiol. 60:252-6","DOI":"10.1016\/j.jjcc.2012.06.010"},{"key":"377_CR15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-12-0033","volume":"76","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Susa T, Tanaka T, Murakami W, Fukuta S, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Okamura T, Yano M, Matsuzaki M (2012) Low-dose \u03b2-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. Circ J 76:1646\u20131653","journal-title":"Circ J"},{"key":"377_CR16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jclinane.2007.05.003","volume":"19","author":"K Goto","year":"2007","unstructured":"Goto K, Shingu C, Miyamoto S, Miyakawa H, Noguchi T (2007) The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth 19:523\u2013529","journal-title":"J Clin Anesth"},{"key":"377_CR17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0735-1097(85)80362-4","volume":"5","author":"RJ Gray","year":"1985","unstructured":"Gray RJ, Bateman TM, Czer LS, Conklin CM, Matloff JM (1985) Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol 5:1451\u20131456","journal-title":"J Am Coll Cardiol"},{"key":"377_CR18","doi-asserted-by":"crossref","unstructured":"Gray RJ. Managing critically ill patients with esmolol (1988) An ultra short-acting beta-adrenergic blocker. Chest 93:398\u2013403","DOI":"10.1378\/chest.93.2.398"},{"key":"377_CR19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0735-1097(94)90411-1","volume":"23","author":"WJ Ko","year":"1994","unstructured":"Ko WJ, Chu SH (1994) A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. J Am Coll Cardiol 23:302\u2013306","journal-title":"J Am Coll Cardiol"},{"key":"377_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.eurheartj.a015311","volume":"18","author":"Intravenous digoxin in acute atrial fibrillation","year":"1997","unstructured":"Intravenous digoxin in acute atrial fibrillation (1997) Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Eur Heart J 18:649\u2013654","journal-title":"Eur Heart J"},{"key":"377_CR21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-8703(98)70031-6","volume":"135","author":"JE Tisdale","year":"1998","unstructured":"Tisdale JE, Padhi ID, Goldberg AD, Silverman NA, Webb CR, Higgins RS, Paone G, Frank DM, Borzak S (1998) A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 135:739\u2013747","journal-title":"Am Heart J"},{"key":"377_CR22","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society (2006) ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257\u2013e354","journal-title":"Circulation"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-013-0377-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0377-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T06:44:31Z","timestamp":1563259471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-013-0377-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,26]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s00380-013-0377-3","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,26]]}}}